Article

BREAKING: One-Year Delay on ICD-10 to October 2014 Finalized

The federal government has finalized a one-year delay in the compliance deadline for the nationwide conversion to ICD-10 code sets. The delay, first proposed in April, will move the compliance deadline to Oct. 1, 2014.

Read the full story: http://tinyurl.com/9al4xja

Source: ModernHealthcare.com

HHS said the extra time would allow healthcare organizations—small organizations in particular—adequate time to get ready for the changeover.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center
Timothy Craig, DO
Hamlet Gasoyan, PhD
EHA 2025 Congress Recap | Image Credit: Venngage
Related Content
The Choose Medicare Act would establish a Medicare “Part E” that would give employers and the general public the option to opt into the program. | Image credit: zimmytws - AdobeStock_45882892
June 17th 2025

Democrats Introduce Bill to Create Public Medicare “Part E”

Rose McNulty
The Choose Medicare Act would establish a Medicare Part E that would give employers and the general public the ability to opt into the program.
Managed Care Cast
June 17th 2025

Managed Care Cast News Roundup: June 17, 2025

Giuliana Grossi
A quick roundup episode of major news and health policy developments from The American Journal of Managed Care.
large B-cell lymphoma | Image credit: Cleveland Clinic
June 17th 2025

Epcoritamab Plus Chemoimmunotherapy Yields 87% Response Rate in R/R DLBCL; 65% Proceed to Transplant

Mary Caffrey
Results show the regimen of epcoritamab plus R-ICE could serve most patients as a bridge to either autologous stem cell transplant or CAR T-cell therapy.
managed care cast logo
June 10th 2025

Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs

Brooke McCormick Julia D. Lucaci, PharmD, MS
Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
FDA Approved. | Image Credit: Nirusmee - stock.adobe.com .jpeg
June 17th 2025

FDA Approves Garadacimab-gxii in Hereditary Angioedema

Pearl Steinzor
Garadacimab-gxii is the first and only treatment that targets factor XIIa (FXIIa) for the prophylactic prevention of hereditary angioedema (HAE) attacks in patients 12 years and older.
Zandraetta Tims-Cook
June 17th 2025

Contributor: PrEP in Practice – How to Start Conversations About HIV Prevention

Zandraetta Tims-Cook, MD, MPH, AAHIVS
Learning the best type of HIV prevention for those at highest risk can start with conversations about their options, writes Zandraetta Tims-Cook, MD, MPH, AAHIVS

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo